))
The World in a Grain of Sand: Schrödinger
Manage episode 382347636 series 3526488
Content provided by KdT Ventures. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KdT Ventures or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Patrick Malone and Mack Healy discuss the biopharma software juggernaut, Schrödinger. We dive into:
- Schrödinger's biophysics-based drug discovery platform, and the distinction from machine learning approaches
- A dissection of Schrödinger's software business, as well as co-development partnerships and internal therapeutic programs
- The story of Schrödinger collaboration with Nimbus on a TYK2 program, resulting in a $4B+ acquisition by Takeda
- and more
For updates from KdT, please subscribe to our Substack.
Show Notes:
13 episodes
Share
